Cynata Therapeutics Ltd
ASX:CYP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Cynata Therapeutics Ltd
ASX:CYP
|
AU |
|
A
|
ADM Korea Inc
KOSDAQ:187660
|
KR |
|
International Frontier Resources Corp
XTSX:IFR
|
CA |
|
V
|
Vistareit Inc
XPHS:VREIT
|
PH |
|
T
|
Tsogo Sun Gaming Ltd
JSE:TSG
|
ZA |
|
Fanhua Inc
NASDAQ:FANH
|
CN |
|
M
|
Mercuries Life Insurance Co Ltd
TWSE:2867
|
TW |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CYP's stock price target?
Not Available
CYP doesn't have any price targets made by Wall Street professionals.
What is Cynata Therapeutics Ltd's Revenue forecast?
Projected CAGR
123%
For the last 13 years the
compound annual growth rate for
Cynata Therapeutics Ltd's revenue is
-3%.
The projected
CAGR
for the next 3 years is
123%.